Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mutations of the human E-cadherin (CDH1) gene.
Berx G, Becker KF, Höfler H, van Roy F. Berx G, et al. Among authors: becker kf. Hum Mutat. 1998;12(4):226-37. doi: 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 1998. PMID: 9744472 Review.
Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA. Vécsey-Semjén B, et al. Among authors: becker kf. Oncogene. 2002 Jul 11;21(30):4646-62. doi: 10.1038/sj.onc.1205577. Oncogene. 2002. PMID: 12096341
Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer.
Lee HJ, Lee HS, Hur K, Kim WH, Yanagihara K, Becker KF, Lee KU, Yang HK. Lee HJ, et al. Among authors: becker kf. J Cancer Res Clin Oncol. 2007 Dec;133(12):987-94. doi: 10.1007/s00432-007-0246-5. Epub 2007 Jun 19. J Cancer Res Clin Oncol. 2007. PMID: 17576594
CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer.
Pharoah PD, Oliveira C, Machado JC, Keller G, Vogelsang H, Laux H, Becker KF, Hahn H, Paproski SM, Brown LA, Caldas C, Huntsman D. Pharoah PD, et al. Among authors: becker kf. Int J Cancer. 2002 Sep 10;101(2):196-7. doi: 10.1002/ijc.10590. Int J Cancer. 2002. PMID: 12209998
Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E, Keller G, Becker I, Rosivatz E, Schott C, Plaschke S, Rudelius M, Hermannstädter C, Busch R, Höfler H, Becker KF, Luber B. Fricke E, et al. Among authors: becker i, becker kf. Int J Cancer. 2003 Mar 10;104(1):60-5. doi: 10.1002/ijc.10879. Int J Cancer. 2003. PMID: 12532420
Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans.
Schwartzkopff S, Gründemann C, Schweier O, Rosshart S, Karjalainen KE, Becker KF, Pircher H. Schwartzkopff S, et al. Among authors: becker kf. J Immunol. 2007 Jul 15;179(2):1022-9. doi: 10.4049/jimmunol.179.2.1022. J Immunol. 2007. PMID: 17617594
E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival.
Gamboa-Dominguez A, Dominguez-Fonseca C, Chavarri-Guerra Y, Vargas R, Reyes-Gutierrez E, Green D, Quintanilla-Martinez L, Luber B, Busch R, Becker KF, Becker I, Höfler H, Fend F. Gamboa-Dominguez A, et al. Among authors: becker kf, becker i. Hum Pathol. 2005 Jan;36(1):29-35. doi: 10.1016/j.humpath.2004.09.020. Hum Pathol. 2005. PMID: 15712179
Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A, Walch A, Fuchs M, Mages J, Duyster J, Keller G, Hermannstädter C, Becker KF, Rauser S, Langer R, von Weyhern CH, Höfler H, Luber B. Bremm A, et al. Among authors: becker kf. Cancer Res. 2008 Feb 1;68(3):707-14. doi: 10.1158/0008-5472.CAN-07-1588. Cancer Res. 2008. PMID: 18245470
Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors.
Laux H, Tomer R, Mader MT, Smida J, Budczies J, Kappler R, Hahn H, Blöchinger M, Schnitzbauer U, Eckardt-Schupp F, Höfler H, Becker KF. Laux H, et al. Among authors: becker kf. Lab Invest. 2004 Oct;84(10):1372-86. doi: 10.1038/labinvest.3700158. Lab Invest. 2004. PMID: 15311212
Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil.
Fricke E, Hermannstädter C, Keller G, Fuchs M, Brunner I, Busch R, Höfler H, Becker KF, Luber B. Fricke E, et al. Among authors: becker kf. Oncology. 2004;66(2):150-9. doi: 10.1159/000077442. Oncology. 2004. PMID: 15138368
169 results
Jump to page
Feedback